Document:

Exhibit 10.1

 

ADVISORY AGREEMENT

 

This ADVISORY AGREEMENT (this “Agreement”)
is made and entered into as of January 1, 2023 (the “Effective Date”), by and between Relmada Therapeutics, Inc.,
a Nevada corporation (the “Company”), and Paul Kelly (the “Advisor”).

 

RECITALS:

 

A. The Company is
a late-stage biotechnology company addressing diseases of the central nervous system, with a focus on major depressive disorder.

 

B.
Advisor has substantial experience in the pharmaceutical and biotech industries.

 

C. The Company desires
to engage Advisor to provide certain advisory services with respect to the Company’s ongoing development on the terms and conditions set
forth in this Agreement.

 

AGREEMENT:

 

NOW THEREFORE, in
consideration of the mutual covenants and agreements contained herein, and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties hereby agree as follows:

 

1. Engagement.
The Company hereby engages Advisor as an independent contractor, and not as an employee, to provide on a non-exclusive basis during the
Advising Term (as defined in Section 3 below) advisory services acting as Special Advisor to the Chief Executive Officer (CEO) to the
Company, and providing the services set forth on Exhibit A hereto (collectively, the “Services”). Advisor shall
render the Services to the Company on a non-exclusive basis and upon the terms and conditions set forth herein. The Company will not treat
Advisor as its employee for federal tax purposes or any other purposes. Advisor will not hold himself out as an employee, officer, director
(except for so long as he is a director of the Corporation) or agent of the Company. This engagement does not create an agency relationship,
and Advisor shall have no authority to bind the Company or make any commitments or public statements on the Company’s behalf. Advisor
agrees to take no action that expresses or implies that the Advisor has such power or authority. Advisor shall not participate in management,
policy affairs or day-to-day decision-making for the Company.

 

2. Method of Performance.
During the Advising Term, Advisor shall provide the Company with the Services in regards to advice, connections and introductions and
such other matters as members of the Company’s Board of Directors (the “Board”) or the Chief Executive Officer may request
and Advisor may agree. Advisor, as an independent contractor, may determine the method, manner and means of performing the Services to
be carried out for the Company. While performing the Services, Advisor shall (a) act in the Company’s best interest at all times, (b)
conduct the Services at the highest professional standards of ethics and integrity, (c) use reasonable good faith efforts and skills to
preserve the business of the Company and the goodwill of employees and persons having business relations with the Company, (d) devote
as much time, energy and effort as is necessary to perform the Services in accordance with the highest professional standards, (e) comply
with all written Company codes of conduct and all written Company policies and procedures that may be implicated by provision of the Services
by an independent contractor and that are provided in advance to Advisor, and (f) conduct the Services in compliance with all applicable
state and federal laws. Advisor hereby consents to have his name, role as Special Advisor to the CEO and curriculum vitae listed on the
Company’s website and in the Company’s marketing materials.

 

3. Term. Unless
extended pursuant to this Section or terminated earlier pursuant to Section 4 below, the initial period of Advisor’s engagement under
this Agreement shall expire on the day prior to the one (1) year anniversary of the Effective Date (the “Initial Term”). Upon
expiration of the Initial Term, this Agreement will automatically renew for consecutive one (1) year terms (each a “Renewal Term”)
unless either party provides the other party written notice of his or its intention to not to renew this Agreement at least thirty (30)
days prior to the end of the Initial Term, or of any Renewal Term once the Agreement has been continued beyond the Initial Term. The period
from the Effective Date until the end of the Initial Term, or any applicable Renewal Term, as the case may be, is hereinafter referred
to as the “Advising Term.”

 

     

     

    

 

4.
Termination.

 

(a) Early
Termination. In the event either party fails to comply with any of the terms of this Agreement and fails to cure such non-compliance
to the reasonable satisfaction of the non-breaching party within fifteen (15) days after receipt of written notice of such breach, the
non-breaching party may immediately terminate this Agreement.

 

(b) Termination
for Cause. The Company may immediately terminate this Agreement for “cause” by giving Advisor written notice of such conduct
and the Company’s intention to terminate. For purposes of this Agreement, “cause” shall mean, with respect to Advisor:

 

(i) the
commission of fraud against the Company, or the misappropriation, theft or embezzlement of the assets of the Company, or the performance
of illegal or fraudulent acts, criminal conduct, or willful misconduct materially injurious to the business of the Company; or

 

(ii) conduct
which materially and adversely affects the Company, or the business, operations, financial condition, or goodwill of the Company.

 

(c)
No Cause Termination.

 

(i) This
Agreement may be terminated at any time by either party by providing the other party with at least thirty (30) days prior written notice
of such party’s intention to terminate this Agreement.

 

(ii) During
any such notice period, Advisor agrees to use his reasonable best efforts to continue his work for the Company and the Company agrees
to continue compensating Advisor until the termination date with the same compensation as before the notice was given.

 

(d) Effect
of Termination. Upon expiration or termination of this Agreement, neither party shall have any further obligations hereunder, except
for obligations incurred prior to the date of expiration or termination. Notwithstanding any termination of this Agreement, the provisions
of Sections 7 through 22 shall survive.

 

5.
Compensation for Services.

 

(a) Cash
Fee. For performing the Services, the Company will pay Advisor monthly in advance Thirty-two Thousand Dollars (US$32,000), with
the first payment payable within seven (7) days after the Effective Date and thereafter at intervals of one (1) month during the
Advising Term .

 

(b) No
Benefits. Advisor (in his capacity as such) is an independent contractor and, as such, Advisor shall not be entitled to participate
in any employment-related benefits that may be provided by the Company, including but not limited to, workers’ compensation insurance,
unemployment compensation insurance, vacation or sick pay, pension or profit sharing benefits, or any type of health, life or disability
insurance.

 

(c) Business
Expense Reimbursement. Advisor will be reimbursed for all customary and reasonable expenses actually incurred in the performance of
the Services, but only to the extent that such business expenses have been pre-approved in writing by the Company. Such reimbursement
will be paid promptly after Advisor has complied with all written policies of the Company regarding reimbursement of expenses.

 

    2

     

    

 

6. Representations
and Warranties. Advisor represents and warrants to the Company as of the Effective Date as follows:

 

(a) Advisor
is under no contractual, judicial or other restraint that impairs his right or legal ability to enter into this Agreement and to carry
out his duties and responsibilities hereunder for the Company;

 

(b) Advisor’s
performance of all the terms of this Agreement will not breach any agreement to keep in confidence proprietary information acquired by
Advisor in confidence or in trust prior to commencement of this Agreement; and

 

(c) Advisor
will not knowingly infringe upon any copyright, patent, trade secret or other property right of any former client or Advisor, employer
or Advisor or third party in the performance of the Services.

 

7. Indemnification.
Advisor hereby agrees to indemnify and hold the Company and its officers, directors, agents, shareholders, representatives and affiliates
(collectively, the “Company Indemnified Parties”) harmless from and against any and all claims, actions, liabilities,
losses, costs, damages, taxes and expenses of any nature whatsoever, including but not limited to judgments, penalties, court costs, reasonable
attorneys’ fees and other costs of investigating and defending any such claim or action (collectively, “Losses”) which
may be asserted against any of the Company Indemnified Parties, arising from (i) the breach of any covenant, obligation, representation
or warranty of Advisor under this Agreement; (ii) the gross negligence or willful misconduct of Advisor in connection with Advisor’s performance
of the Services during the Advising Term; and/or (iii) the Company’s treatment of Advisor as an independent contractor rather than treating
Advisor as an employee for tax purposes (collectively referred to as the “Company Indemnified Matters”). To the fullest
extent permitted by law, Advisor shall pay all expenses, including attorneys’ fees, actually and necessarily incurred by the Company in
connection with the defense of any complaint, action, suit, or proceeding relating to the Company Indemnified Matters. The Company hereby
agrees to indemnify and hold Advisor and his successors and assigns and their heirs, estate and representatives (collectively, the “Advisor
Indemnified Parties”) harmless from and against any and all Losses which may be asserted against any of the Advisor Indemnified
Parties, arising from the breach of any covenant, obligation, representation or warranty of the Company under this Agreement (collectively
referred to as the “Advisor Indemnified Matters”). To the fullest extent permitted by law, Advisor shall pay all expenses,
including attorneys’ fees, actually and necessarily incurred by the Company in connection with the defense of any complaint, action, suit,
or proceeding relating to the Advisor Indemnified Matters.

 

8. Confidential
Information. The Company will provide Advisor with certain Confidential Information (as defined below) in order to allow Advisor to
perform the Services. Advisor acknowledges that the Confidential Information is the property of the Company. Therefore, Advisor agrees
that he shall not disclose or permit to be disclosed, without the prior written consent of the Board of Directors or Chief Executive Officer
of the Company, any Confidential Information other than as necessary to perform the Services. Advisor agrees that during the Advising
Term and following the termination of his engagement with the Company for any reason, he will not directly or indirectly use any Confidential
Information for any reason other than the advancement of the Company’s business interests. For purposes of this Agreement, the term “Confidential
Information” means, collectively, all information and data regarding the Company including, without limitation, the Company’s
partnerships, joint ventures, shareholders, officers, directors, employees, agents, representatives, independent contractors, subcontractors,
clients, customers, vendors, suppliers, developers, lenders, investors, budgets, research, analysis, studies, real and personal properties,
intellectual properties, licenses, license agreements, projects, expenses, fees, charges, pricing, assets, services, computer hardware
and software, data files, spreadsheets, operations, financial statements, marketing plans, methods, processes, business plans, and financial
performance, at any time obtained by Advisor in connection with Advisor’s engagement by the Company. Notwithstanding the foregoing, the
term Confidential Information shall not include any information that (a) is or becomes generally available to the public (other than as
a result of violation of this Agreement by Advisor), (b) at the time of disclosure by the Company is already known by Advisor free of
any obligation of confidentiality to a source other than the Company; or (c) Advisor receives on a non-confidential basis from a source
other than the Company that is not known by Advisor to be bound by an obligation of secrecy or confidentiality. If Advisor is requested
in any legal proceeding to disclose any Confidential Information, Advisor agrees to give the Company prompt notice of such request so
that the Company may seek an appropriate protective order all at the Company’s sole cost and expense. If Advisor is nonetheless compelled
to disclose any Confidential Information by a court, subpoena, legal proceeding or governmental body having the authority to order such
disclosure, Advisor may disclose the Confidential Information without liability hereunder; provided, however, that if permitted
to do so by the law, order or legal process, Advisor gives the Company written notice of the Confidential Information to be disclosed
as far in advance of its disclosure as is practicable and, upon the Company’s request, Advisor uses his good faith efforts to obtain assurances
that confidential treatment will be accorded to the Confidential Information (at the sole cost and expense of the Company).

 

    3

     

    

 

9. Return of Property
to the Company. Upon the termination of his engagement with the Company for any reason, Advisor agrees to promptly return to the Company
all Company-owned property in his possession or control, including, without limitation, all Confidential Information. After the termination
of his engagement with the Company, Advisor agrees that he will not retain copies of any Confidential Information or any other documents
or property belonging to the Company.

 

10. Independent
Contractor Status. Advisor shall be an independent contractor and not an employee, agent, joint venturer, or partner of the
Company by virtue of this Agreement. Nothing in this Agreement shall be interpreted or construed as creating or establishing the
relationship of employer and employee between the Company, on the one hand, and Advisor on the other hand. Neither Advisor nor the
Company has any authority to act for or on behalf of the other, nor to bind the other to any contract or in any other manner without
the express approval in writing of the other. The Company shall not be required to pay on account of Advisor, and pursuant to
Section 7 of this Agreement Advisor shall indemnify and hold the Company harmless from, (a) all federal, state, local or foreign
income or other taxes applicable to any compensation (whether cash, securities or other) paid or issued to the Adviser pursuant to
this Agreement, and (b) any costs, expenses or claims associated with the payment, on account of Advisor, of any unemployment tax or
other employees’ taxes required under law to be paid with respect to Advisor; nor shall the Company be required to withhold
any monies from any payments made hereunder to Advisor for income tax purposes or with respect to any other applicable deductions
required by law.

 

11. Choice of
Law. The parties agree that this Agreement shall be construed under the substantive laws of the State of New York, without regard
to its conflicts of law principles to the extent such principles or rules would require or permit the application of the laws of any jurisdiction
other than those of the State of New York.

 

12. Jurisdiction
and Venue. Any judicial proceeding brought by or against either of the parties to this Agreement on any dispute arising out of this
Agreement or any matter relating thereto shall be brought in any federal or state court sitting in the Borough of Manhattan in the City
and State of New York, and by execution and delivery of this Agreement, each of the parties hereto hereby accepts for himself or itself
the exclusive jurisdiction and venue of the aforesaid courts as trial courts, and irrevocably agrees to be bound by any final non-appealable
judgment rendered in connection with this Agreement.

 

13. WAIVER OF
JURY TRIAL. EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHTS HE OR IT MAY HAVE TO DEMAND THAT ANY ACTION, PROCEEDING
OR COUNTERCLAIM ARISING OUT OF OR IN ANY WAY RELATED TO THIS AGREEMENT OR THE RELATIONSHIPS OF THE PARTIES HERETO BE TRIED BY JURY. THIS
WAIVER EXTENDS TO ANY AND ALL RIGHTS TO DEMAND A TRIAL BY JURY ARISING FROM ANY SOURCE INCLUDING, BUT NOT LIMITED TO, THE CONSTITUTION
OF THE UNITED STATES OR ANY STATE THEREIN, COMMON LAW OR ANY APPLICABLE STATUTE OR REGULATIONS. EACH PARTY HERETO ACKNOWLEDGES THAT HE
OR IT IS KNOWINGLY AND VOLUNTARILY WAIVING HIS OR ITS RIGHT TO DEMAND TRIAL BY JURY.

 

14. Remedies.
All remedies provided for in this Agreement will be cumulative and in addition to and not in lieu of any other remedies available to either
party at law, in equity or otherwise.

 

15. Severability.
If any provision of this Agreement is declared or found to be illegal, unenforceable, or void, in whole or in part, then all parties will
be relieved of all obligations thereunder, but only to the extent such provision is illegal, unenforceable, or void. The parties intend
that this Agreement will be deemed amended by modifying any such illegal, unenforceable, or void provision to the extent necessary to
make it legal and enforceable while preserving its intent, or if such is not possible, by substituting therefor another provision that
is legal and enforceable and achieves the same objectives. Notwithstanding the foregoing, if the remainder of this Agreement will not
be affected by such declaration or finding and is capable of substantial performance, then each provision not so affected will be enforced
to the extent permitted by law.

 

    4

     

    

 

16. Waiver.
No delay or omission by either party to this Agreement to exercise any right or power under this Agreement will impair such right or power
or be construed as a waiver thereof. A waiver by any party to this Agreement of any of the covenants to be performed by any other party
or any breach thereof will not be construed to be a waiver of any succeeding breach thereof or of any other covenant contained in this
Agreement.

 

17. No Assignment.
Neither this Agreement nor any right or interest hereunder shall be assignable by Advisor or his beneficiaries or legal representatives
without the Company’s prior written consent. This Agreement may not be assigned by the Company except with Advisor’s prior written consent.
Any attempted assignment without the requisite consent shall be void and of no effect.

 

18. Notices.
Any notices, consents, demands, requests, approvals and other communications to be given under this Agreement by either party to the other
shall be deemed to have been duly given if given in writing and personally delivered or sent by mail (registered or certified) or by a
nationally recognized overnight delivery service, the business day on which the notice is actually received by the party, or if given
by certified mail, return receipt requested, postage prepaid, five (5) business days after posted with the United States Postal Service,
addressed as follows:

 

(a)
if to the Company, to:

 

Relmada Therapeutics, Inc.

2222 Ponce de Leon Blvd., Floor 3

 Coral Gables, FL 33134

Email: cence@relmada.com 

Telephone: +1 (786) 629 1376

 

or to such other address as the Company may have advised Advisor
in writing; and

 

(b)
if to Advisor, to:

 

Paul Kelly

[address]

Email: pkelly@relmada.com

Telephone: [____________]

 

or to such other address as Advisor may have advised the Company
in writing.

 

19.
Entire Agreement. This Agreement represents the entire agreement relating to the relationship between the Company and Advisor
with respect to the Services to be provided by Advisor as described herein. No prior or subsequent promises, representations, or understandings
relative to any terms or conditions of Advisor’s engagement are to be considered binding or part of this Agreement unless expressly agreed
to in a writing signed by the parties. Notwithstanding the foregoing, nothing in this Agreement shall be construed to limit or derogate
from the rights and obligations of the Advisor, on the one hand, and the Company, on the other hand, under any other agreement not relating
to the Services, or under applicable law in connection with the Advisor’s service, past, present, or future, as a director of the
Company.

 

20. Amendment.
This Agreement may be amended only in a writing signed by the Company and the Advisor.

 

21. Counterparts.
This Agreement may be executed in multiple counterparts, each of which shall be deemed an original for all purposes and all of which shall
be deemed collectively to be one agreement. Signatures given by facsimile or portable document format (or similar format) shall be binding
and effective to the same extent as original signatures.

 

22. Acknowledgment.
By signing below, the parties certify and represent that they have carefully read and considered the foregoing Agreement and fully understand
all provisions of this Agreement and understand the consequences of signing this Agreement, and have signed this Agreement voluntarily
and without coercion, undue influence, threat, or intimidation of any kind or type whatsoever.

 

[The Remainder of This Page Is Intentionally
Left Blank.]

 

    5

     

    

 

IN WITNESS WHEREOF, the Company and Advisor
have executed this Agreement as of the Effective Date.

 

	COMPANY:	RELMADA THERAPEUTICS, INC.,
	 	a Nevada corporation
	 	 	 
	 	By:	/s/ Sergio Traversa
	 	 	Name: 	Sergio Traversa
	 	 	Title:	CEO
	 	 	 	 
	ADVISOR:	 	 
	 	 	 
	 	 	/s/ Paul Kelly
	 	 	Paul Kelly

 

    6

     

    

 

EXHIBIT A

 

SERVICES

 

During the Advising Term, Advisor shall provide the following
Services:

 

		●	Strategy formation, operational and research and development
counsel as requested by the Chief Executive Officer and Board of Directors

 

		●	Work in coordination with the Company’s
management to develop internal and external corporate opportunities

 

		●	For potential acquisitions, coordinate with management to
identify specific acquisition candidates and/or partnership opportunities through direct relationships

 

		●	For potential divestitures, coordinate closely with management
and business teams to identify divestiture candidates and prepare launch materials

 

		●	Valuation and due diligence: assist in internal due diligence
and financial analysis (e.g., discounted cash flow, precedent transactions, comparable companies, pro forma earnings accretion / dilution
and pro forma credit analysis) to evaluate selected opportunities

 

		●	Support key relationships and dialogue with investment banks
and other financial advisors to track industry trends, as well as to identify target acquisition and divestiture opportunitiesExhibit 10.25

 

EXECUTION VERSION

 

December 29, 2022

 

Kenneth Siegel

Via Email Delivery

 

	Re:	Separation Agreement

 

Dear Ken:

 

This letter sets forth the separation agreement
(the “Agreement”) that SenesTech, Inc. (the “Company”) is offering to you to aid in your employment
transition.

 

1. SEPARATION
DATE. Your last day of employment with the Company was November 15, 2022 (the “Separation Date”). The Company has
paid you all accrued salary, and all accrued and unused vacation earned through the Separation Date, subject to standard payroll deductions
and withholdings. By your execution of this Agreement, you are also hereby resigning from your position on the Company’s Board of
Directors (the “Board”) effective as of December 31, 2022, and the Company hereby accepts such resignation to
be effective as of such date.

 

2. SEVERANCE
BENEFITS. If you timely sign this Agreement and allow the releases set forth herein to become effective, and comply with your obligations
hereunder, then the Company will provide you with the following severance benefits, which you and the Company acknowledge are more favorable
to you than, and are in lieu of, the severance benefits set forth in your May 16, 2019, employment agreement with the Company (the “Employment
Agreement”) for a termination without Cause:

 

(a) Severance
Pay. The Company will pay you the equivalent of twelve (12) months of your base salary in effect as of the Separation Date, subject
to standard payroll deductions and withholdings (“Severance Pay”), paid in the form of salary continuation over the
twelve (12) month period following the Separation Date. The Severance Pay shall start on the first regular Company payroll date that falls
on or after the 60th day following the Separation Date, with the first payment to include those payments that you otherwise would have
been paid during such 60-day period.

 

(b) COBRA.
If you timely and validly elect continued coverage under COBRA, the Company will pay your COBRA premiums to continue your coverage (including
coverage for eligible dependents, if applicable) through the period (the “COBRA Premium Period”) starting on the Separation
Date and ending on the earliest to occur of: (i) November 30, 2023; (ii) the date you become eligible for group health insurance coverage
through a new employer; or (iii) the date you cease to be eligible for COBRA continuation coverage for any reason, including plan termination.
In the event you become covered under another employer’s group health plan or otherwise cease to be eligible for COBRA during the
COBRA Premium Period, you shall immediately notify the Company in writing of such event. Following the COBRA Premium Period, you may be
eligible for additional COBRA continuation coverage at your own expense. Later, you may be able to convert to an individual policy through
the provider of the Company’s health insurance, if you wish.

 

     

     

    

 

(c) Acceleration.
The Company will accelerate the vesting on all of your outstanding equity awards such that you will be deemed fully vested in all such
awards. The outstanding equity awards are listed on Schedule A to this Agreement. Notwithstanding anything in the applicable equity award
agreements, grant notices, or plan documents, all of your outstanding equity awards will be exercisable until the date that is five (5)
years after the Separation Date, at which time all such awards will terminate and be of no further force or effect. Except as set forth
in this Section 2(c), your outstanding equity awards shall continue to be governed in all respects by the terms of the applicable equity
award agreements, grant notices, and plan documents.

 

3. TRANSITIONAL
MATTERS. As a precondition to your receipt of the severance benefits described in this Agreement, you agree, and are required, to
cooperate promptly and thoroughly with respect to any request the Company may reasonably make for information about the status of any
work you were performing for the Company. Without limiting the generality of the foregoing, you agree that you will be available to assist
the Company for a minimum of 10 hours per week from the Separation Date through December 31, 2022 (the “Transition Period”).
During the Transition Period, you will be “Executive Director”, and may use such title in connection with your assistance
to the Company and in your communications regarding the transition. For the avoidance of doubt, you will not be an officer of the Company
following the Separation Date, and will not have authority to bind the Company in any matter following the Separation Date. Compensation
for any consulting services shall be paid at a rate equal to your annual salary converted to an hourly rate based on an assumed 40 hour
work week.

 

4. OTHER
COMPENSATION OR BENEFITS. You acknowledge that, except as expressly provided in this Agreement, you will not receive any additional
compensation, severance or benefits after the Separation Date, with the exception of any vested right you may have under the express terms
of a written ERISA-qualified benefit plan (e.g., 401(k) account). You acknowledge and agree that you have not earned, are not owed and
will not receive, any annual bonus for 2022. You further acknowledge that upon receipt of the severance benefits set forth in this Agreement,
you will have received all severance benefits you are entitled to receive from the Company, whether under the Employment Agreement or
otherwise.

 

5. EXPENSE
REIMBURSEMENTS. You agree that, within ten (10) days after the Transition Period, you will submit your final documented expense reimbursement
statement reflecting all business expenses you incurred through the Transition Period, if any, for which you seek reimbursement. The Company
will reimburse you for these expenses pursuant to its regular business practice.

 

6. RETURN
OF COMPANY PROPERTY. By signing below, you represent and warrant that you have returned to the Company all proprietary and/or confidential
Company documents (and all copies thereof) and other Company property in your possession or control. You further represent that you have
made a diligent search to locate any such documents, property and information. In addition, if you have used any personally owned computer,
server, or e-mail system to receive, store, review, prepare or transmit any confidential or proprietary data, materials or information
of the Company, then within five (5) business days after the Separation Date, if requested by the Company, you must provide the Company
with a computer-useable copy of such information and then permanently delete and expunge such confidential or proprietary information
from those systems without retaining any reproductions (in whole or in part). Your timely compliance with the provisions of this paragraph
is a precondition to your receipt of the severance benefits provided hereunder.

 

    2

     

    

 

7. PROPRIETARY
INFORMATION OBLIGATIONS. As a precondition to your receipt of the severance benefits set forth herein, you are required to execute
the Confidential Information and Inventions Assignment Agreement attached hereto as Exhibit A.

 

8. NONDISPARAGEMENT.
You agree not to disparage the Company or the Company’s officers, directors, employees, shareholders, parents, subsidiaries, affiliates,
and agents, in any manner likely to be harmful to them or their business, business reputation or personal reputation, and the Company
agrees that the members of its Board and Company officers will not disparage you in any manner likely to be harmful to your personal or
professional reputations; provided that both you and the Company may respond accurately and fully to any question, inquiry or request
for information when required by legal process. In addition, nothing in this provision or this Agreement is intended to prohibit or restrain
you in any manner from making disclosures that are protected under the whistleblower provisions of federal or state law or regulation.

 

9. NO
VOLUNTARY ADVERSE ACTION. You agree that you will not voluntarily assist any person in bringing or pursuing any claim or action of
any kind against the Company or its parents, subsidiaries, affiliates, officers, directors, employees or agents, unless pursuant to subpoena
or other compulsion of law. For purposes of clarity, the foregoing shall not be construed to preclude you from pursuing any claim or action
to enforce the Company’s obligations under this Agreement. In addition, you agree to execute all additional documents (if any) necessary
to carry out the terms of this Agreement, such as but not exclusive of assignments, declarations and other documents necessary for procurement
and enforcement of IP rights globally; provided that the Company shall promptly reimburse you for the actual and reasonable attorneys’
fees incurred by you in connection with the review of any such additional documents (for the avoidance of doubt, the Company shall not
reimburse you for fees incurred by you in connection with the review of this Agreement or the Exhibits or Schedules to this Agreement).

 

10. NO
ADMISSIONS. You understand and agree that the promises and payments in consideration of this Agreement shall not be construed to be
an admission of any liability or obligation by the Company to you or to any other person, and that the Company makes no such admission.

 

11. YOUR
RELEASE OF CLAIMS.

 

(a) General
Release. In exchange for the consideration provided to you under this Agreement to which you would not otherwise be entitled, you
hereby generally and completely release the Company, and its affiliated, related, parent and subsidiary entities, and its and their current
and former directors, officers, employees, shareholders, partners, agents, attorneys, predecessors, successors, insurers, affiliates,
and assigns (collectively, the “Released Parties”) from any and all claims, liabilities and obligations, both known
and unknown, that arise out of or are in any way related to events, acts, conduct, or omissions relating to or arising out of your employment
by the Company and occurring prior to or on the date you sign this Agreement (collectively, the “Released Claims”).

 

    3

     

    

 

(b) Scope
of Release. The Released Claims include, but are not limited to: (i) all claims arising out of or in any way related to your
employment with the Company, or the termination of that employment; (ii) all claims related to your compensation or benefits from the
Company, including salary, bonuses, commissions, vacation, expense reimbursements, severance pay, fringe benefits, stock, stock options,
or any other ownership, equity, or profits interests in the Company; (iii) all claims for breach of contract, wrongful termination, and
breach of the implied covenant of good faith and fair dealing; (iv) all tort claims, including claims for fraud, defamation, emotional
distress, and discharge in violation of public policy; and (v) all federal, state, and local statutory claims, including claims for discrimination,
harassment, retaliation, attorneys’ fees, or other claims arising under the federal Civil Rights Act of 1964 (as amended), the federal
Americans with Disabilities Act of 1990, the federal Age Discrimination in Employment Act of 1967 (as amended) (the “ADEA”),
the California Labor Code (as amended), the California Fair Employment and Housing Act (as amended), and all state law claims under Arizona
law.

 

(c) ADEA
Waiver. You acknowledge that you are knowingly and voluntarily waiving and releasing any rights you may have under the ADEA and that
the consideration given for this waiver is in addition to anything of value to which you are already entitled. You further acknowledge
that you have been advised, as required by the ADEA, that: (i) your waiver does not apply to any rights or claims that may arise after
the date that you sign this Agreement; (ii) you should consult with an attorney prior to signing this Agreement (although you may choose
voluntarily not to do so); (iii) you will have at least twenty-one (21) days to consider this Agreement (although you may choose voluntarily
to sign it earlier); (iv) you have seven (7) days following the date you sign this Agreement to revoke your acceptance of this Agreement
(by providing written notice of your revocation to me); and (v) this Agreement will not be effective until the date upon which the revocation
period has expired, which will be the eighth day after the date that this Agreement is signed by you provided that you do not revoke it
(the “Effective Date”).

 

(d) Section
1542 Waiver. YOU UNDERSTAND THAT THIS AGREEMENT INCLUDES A RELEASE OF ALL KNOWN AND UNKNOWN CLAIMS. In giving the release herein,
which includes claims which may be unknown to you at present, you acknowledge that you have read and understand Section 1542 of the California
Civil Code, which reads as follows: “A general release does not extend to claims which the creditor or releasing party does not
know or suspect to exist in his or her favor at the time of executing the release, which if known by him or her would have materially
affected his or her settlement with the debtor or released party.” You hereby expressly waive and relinquish all rights and
benefits under that section and any law of any other jurisdiction of similar effect with respect to your release of any unknown or unsuspected
claims herein.

 

    4

     

    

 

(e) Excluded
Claims. Notwithstanding the foregoing, the following are not included in the Released Claims (the “Excluded Claims”):
(i) any rights or claims for defense and/or indemnification you may have pursuant to any written indemnification agreement with the Company
to which you are a party or under applicable law; (ii) any rights which are not waivable as a matter of law; and (iii) any claims for
breach of this Agreement and/or any breach of the applicable benefit plan or equity incentive plan documents governing the benefits (severance
or otherwise) payable to you hereunder, to the extent such breach occurs subsequent to the date hereof. You hereby represent and warrant
that, other than the Excluded Claims, you are not aware of any claims you have or might have against any of the Released Parties that
are not included in the Released Claims. You understand that nothing in this Agreement limits your ability to file a charge or complaint
with the Equal Employment Opportunity Commission, the Department of Labor, the National Labor Relations Board, the Occupational Safety
and Health Administration, the Securities and Exchange Commission or any other federal, state or local governmental agency or commission
(“Government Agencies”). You further understand this Agreement does not limit your ability to communicate with any
Government Agencies or otherwise participate in any investigation or proceeding that may be conducted by any Government Agency, including
providing documents or other information, without notice to the Company. While this Agreement does not limit your right to receive an
award for information provided to the Securities and Exchange Commission or any other Government Agency, you understand and agree that,
to maximum extent permitted by law, you are otherwise waiving any and all rights you may have to individual relief based on any claims
that you have released and any rights you have waived by signing this Agreement.

 

12. THE
COMPANY’S RELEASE OF CLAIMS. In exchange for your execution of this Agreement, including the release you are granting pursuant
to Section 11 above, the Company generally and completely releases you, your heirs, agents, and attorneys from any and all claims, liabilities
and obligations, both known and unknown, that arise out of or are in any way related to events, acts, conduct, or omissions occurring
prior to or on the date you sign this Agreement; provided, however, that this release shall not extend to claims arising at any time from
your contractual and statutory obligations to refrain from the unauthorized use or disclosure of proprietary or trade secret information
belonging to the Company, nor to any claims arising at any time from your willful misconduct that causes material injury to the Company
or its shareholders. (These two exceptions shall, collectively, be deemed “the Exceptions.”) The Company represents
that it has no present intention to bring claims against you that fall within the Exceptions and that, as of the date hereof, it has no
actual knowledge of any such claims against you that fall within the Exceptions. The Company understands that its release extends to all
known and unknown claims, and the Company acknowledges that it has read and understands Section 1542 of the California Civil Code, which
reads as noted in Section 11(d) above. The Company expressly waives and relinquishes all rights and benefits under that section and any
law of any other jurisdiction or similar effect with respect to its release of any unknown or unsuspected claims herein.

 

13. REPRESENTATIONS.
Subject to the Company’s compliance with its obligations to provide the severance benefits and other payments set forth in this
agreement, you hereby represent that you have been paid all compensation owed and for all hours worked, have received all the leave and
leave benefits and protections for which you are eligible, pursuant to the Family and Medical Leave Act or otherwise, and, to your knowledge,
have not suffered any on-the-job injury for which you have not already filed a claim.

 

    5

     

    

 

14. DISPUTE
RESOLUTION. To aid in the rapid and economical resolution of any disputes which may arise under this Agreement, you and the Company
agree that any and all claims, disputes or controversies of any nature whatsoever arising from or regarding the interpretation, performance,
negotiation, execution, enforcement or breach of this Agreement, your employment, or the termination of your employment, including but
not limited to statutory claims, shall be resolved, to the greatest extent permitted by law, by confidential, final and binding arbitration
conducted before a single arbitrator with the American Arbitration Association (“AAA”) in Phoenix, Arizona under AAA’s
then-applicable arbitration rules. The parties acknowledge that, by agreeing to this arbitration procedure, they waive the right to
resolve any such dispute through a trial by jury, judge or administrative proceeding. You will have the right to be represented by
legal counsel at any arbitration proceeding. The arbitrator shall: (a) have the authority to compel adequate discovery for the resolution
of the dispute and to award such relief as would otherwise be available under applicable law in a court proceeding; and (b) issue a written
statement signed by the arbitrator regarding the disposition of each claim and the relief, if any, awarded as to each claim, the reasons
for the award, and the arbitrator’s essential findings and conclusions on which the award is based. The Company shall bear the arbitration
association’s arbitration fees and administrative costs. Nothing in this Agreement shall prevent either you or the Company from
obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any such arbitration. Any awards or orders
in such arbitrations may be entered and enforced as judgments in the federal and state courts of any competent jurisdiction.

 

15. GENERAL.
This Agreement, including Schedule A and Exhibit A, constitutes the complete, final and exclusive embodiment of the entire agreement
between you and the Company with regard to this subject matter. It is entered into without reliance on any promise or representation,
written or oral, other than those expressly contained herein, and it supersedes any other such promises, warranties or representations.
This Agreement may not be modified or amended except in a writing signed by both you and a duly authorized officer of the Company. This
Agreement will bind the heirs, personal representatives, successors and assigns of both you and the Company, and inure to the benefit
of both you and the Company, their heirs, successors and assigns. If any provision of this Agreement is determined to be invalid or unenforceable,
in whole or in part, this determination will not affect any other provision of this Agreement and the provision in question will be modified
by the court so as to be rendered enforceable to the fullest extent permitted by law, consistent with the intent of the parties. This
Agreement will be deemed to have been entered into and will be construed and enforced in accordance with the laws of the State of Arizona
as applied to contracts made and to be performed entirely within Arizona.

 

Any amounts payable to you under this Agreement,
if not timely paid, will bear interest at the rate of 18% per annum until paid in full.

 

If this Agreement is acceptable to you, please sign below and return
the original to me. You must return this signed Agreement, with the revocation period having elapsed, within sixty (60) days.

 

I wish you good luck in your future endeavors. Sincerely,

 

SENESTECH, INC.

 

	By:	/s/ Jamie Bechtel	 
	 	Jamie Bechtel, Director	 

 

ACCEPTED AND AGREED:

 

	/s/ Kenneth Siegel	 
	Kenneth Siegel	 
	 	 
	December 30, 2022	 
	Date	 

 

    6

     

    

 

SCHEDULE A

 

	 	 	Number of Shares	 	 	Exercise Price Per Share	 	 	Grant

 Date	 	Original Expiration Date	 	New

 Expiration

 Date
	Siegel, Ken	 	 	21	 	 	$	341.720	 	 	2/14/19	 	2/14/24	 	11/15/27
	Siegel, Ken	 	 	1,750	 	 	$	568.000	 	 	6/18/19	 	5/16/29	 	11/15/27
	Siegel, Ken	 	 	5,099	 	 	$	36.000	 	 	7/31/20	 	7/31/25	 	11/15/27
	Siegel, Ken	 	 	6,000	 	 	$	31.800	 	 	5/3/21	 	5/3/26	 	11/15/27
	Siegel, Ken	 	 	7,500	 	 	$	16.378	 	 	2/17/22	 	2/17/27	 	11/15/27

 

    Sch A-1

     

    

 

EXHIBIT A

 

PROPRIETARY INFORMATION AND INVENTIONS AGREEMENT

 

CONFIDENTIAL INFORMATION

AND

INVENTIONS ASSIGNMENT AGREEMENT

 

In consideration of my Separation
Agreement with SenesTech, Inc. (“Company”), and the compensation paid to me pursuant to the Separation Agreement with
the Company, I agree to the terms of this Agreement as follows:

 

1.
CONFIDENTIAL INFORMATION PROTECTIONS.

 

1.1 Nondisclosure;
Recognition of Company’s Rights. At all times during and after my employment, I will hold in confidence and will not disclose,
use, lecture upon, or publish any of Company’s Confidential Information (defined below), except as may be required in connection
with my work for Company, or as expressly authorized by the Chief Executive Officer (the “CEO”) of Company. I will
obtain the CEO’s written approval before publishing or submitting for publication any material (written, oral, or otherwise) that
relates to my work at Company and/or incorporates any Confidential Information. I hereby assign to Company any rights I may have or acquire
in any and all Confidential Information and recognize that all Confidential Information shall be the sole and exclusive property of Company
and its assigns.

 

1.2 Confidential
Information. The term “Confidential Information” shall mean any and all confidential knowledge, data or information
related to Company’s business or its actual or demonstrably anticipated research or development, including without limitation (a)
trade secrets, inventions, ideas, processes, computer source and object code, data, formulae, programs, other works of authorship, know-how,
improvements, discoveries, developments, designs, and techniques; (b) information regarding products, services, plans for research and
development, marketing and business plans, budgets, financial statements, contracts, prices, suppliers, and customers; (c) information
regarding the skills and compensation of Company’s employees, contractors, and any other service providers of Company; and (d) the
existence of any business discussions, negotiations, or agreements between Company and any third party.

 

    Ex A-1

     

    

 

1.3 Third
Party Information. I understand that Company has received and in the future will receive from third parties confidential or proprietary
information (“Third Party Information”) subject to a duty on Company’s part to maintain the confidentiality of
such information and to use it only for certain limited purposes. During and after the term of my employment, I will hold Third Party
Information in strict confidence and will not disclose to anyone (other than Company personnel who need to know such information in connection
with their work for Company) or use, Third Party Information, except in connection with my work for Company or unless expressly authorized
by an officer of Company in writing.

 

1.4 No
Improper Use of Information of Prior Employers and Others. I represent that my employment by Company does not and will not breach
any agreement with any former employer, including any noncompete agreement or any agreement to keep in confidence or refrain from using
information acquired by me prior to my employment by Company. I further represent that I have not entered into, and will not enter into,
any agreement, either written or oral, in conflict with my obligations under this Agreement. During my employment by Company, I will not
improperly make use of, or disclose, any information or trade secrets of any former employer or other third party, nor will I bring onto
the premises of Company or use any unpublished documents or any property belonging to any former employer or other third party, in violation
of any lawful agreements with that former employer or third party. I will use in the performance of my duties only information that is
generally known and used by persons with training and experience comparable to my own, is common knowledge in the industry or otherwise
legally in the public domain, or is otherwise provided or developed by Company.

 

2.
INVENTIONS.

 

2.1 Definitions.
As used in this Agreement, the term “Invention” means any ideas, concepts, information, materials, processes, data,
programs, know-how, improvements, discoveries, developments, designs, artwork, formulae, other copyrightable works, and techniques and
all Intellectual Property Rights in any of the items listed above. The term “Intellectual Property Rights” means all
trade secrets, copyrights, trademarks, mask work rights, patents and other intellectual property rights recognized by the laws of any
jurisdiction or country. The term “Moral Rights” means all paternity, integrity, disclosure, withdrawal, special and
any other similar rights recognized by the laws of any jurisdiction or country.

 

2.2 Prior
Inventions. I have disclosed on Exhibit A a complete list of all Inventions that (a) I have, or I have caused to be, alone or jointly
with others, conceived, developed, or reduced to practice prior to the commencement of my employment by Company; (b) in which I have an
ownership interest or which I have a license to use; (c) and that I wish to have excluded from the scope of this Agreement (collectively
referred to as “Prior Inventions”). If no Prior Inventions are listed in Exhibit A, I warrant that there are
no Prior Inventions. I agree that I will not incorporate, or permit to be incorporated, Prior Inventions in any Company Inventions (defined
below) without Company’s prior written consent. If, in the course of my employment with Company, I incorporate a Prior Invention
into a Company process, machine or other work, I hereby grant Company a non-exclusive, perpetual, fully-paid and royalty-free, irrevocable
and worldwide license, with rights to sublicense through multiple levels of sublicensees, to reproduce, make derivative works of, distribute,
publicly perform, and publicly display in any form or medium, whether now known or later developed, make, have made, use, sell, import,
offer for sale, and exercise any and all present or future rights in, such Prior Invention.

 

    Ex A-2

     

    

 

2.3 Assignment
of Company Inventions. Inventions assigned to the Company or to a third party as directed by the Company pursuant to the subsection
titled Government or Third Party are referred to in this Agreement as “Company Inventions.” Subject to the subsection
titled Government or Third Party and except for Inventions that I can prove qualify fully under the provisions of California Labor Code
section 2870 and I have set forth in Exhibit A, I hereby assign and agree to assign in the future (when any such Inventions or
Intellectual Property Rights are first reduced to practice or first fixed in a tangible medium, as applicable) to Company all my right,
title, and interest in and to any and all Inventions (and all Intellectual Property Rights with respect thereto) made, conceived, reduced
to practice, or learned by me, either alone or with others, during the period of my employment by Company. Any assignment of Inventions
(and all Intellectual Property Rights with respect thereto) hereunder includes an assignment of all Moral Rights. To the extent such Moral
Rights cannot be assigned to Company and to the extent the following is allowed by the laws in any country where Moral Rights exist, I
hereby unconditionally and irrevocably waive the enforcement of such Moral Rights, and all claims and causes of action of any kind against
Company or related to Company’s customers, with respect to such rights. I further acknowledge and agree that neither my successors-in-interest
nor legal heirs retain any Moral Rights in any Inventions (and any Intellectual Property Rights with respect thereto).

 

2.4 Obligation
to Keep Company Informed. During the period of my employment and for one (1) year after my employment ends, I will promptly and fully
disclose to Company in writing (a) all Inventions authored, conceived, or reduced to practice by me, either alone or with others, including
any that might be covered under California Labor Code section 2870, and (b) all patent applications filed by me or in which I am
named as an inventor or co-inventor.

 

2.5 Government
or Third Party. I agree that, as directed by the Company, I will assign to a third party, including without limitation the United
States, all my right, title, and interest in and to any particular Company Invention.

 

2.6 Enforcement
of Intellectual Property Rights and Assistance. During and after the period of my employment and at Company’s request and expense,
I will assist Company in every proper way, including consenting to and joining in any action, to obtain and enforce United States and
foreign Intellectual Property Rights and Moral Rights relating to Company Inventions in all countries. If the Company is unable to secure
my signature on any document needed in connection with such purposes, I hereby irrevocably designate and appoint Company and its duly
authorized officers and agents as my agent and attorney in fact, which appointment is coupled with an interest, to act on my behalf to
execute and file any such documents and to do all other lawfully permitted acts to further such purposes with the same legal force and
effect as if executed by me.

 

    Ex A-3

     

    

 

2.7 Incorporation
of Software Code. I agree that I will not incorporate into any Company software or otherwise deliver to Company any software code
licensed under the GNU General Public License or Lesser General Public License or any other license that, by its terms, requires or conditions
the use or distribution of such code on the disclosure, licensing, or distribution of any source code owned or licensed by Company.

 

3. RECORDS.
I agree to keep and maintain adequate and current records (in the form of notes, sketches, drawings and in any other form that is required
by the Company) of all Inventions made by me during the period of my employment by the Company, which records shall be available to, and
remain the sole property of, the Company at all times.

 

4. ADDITIONAL
ACTIVITIES. I agree that during the term of my employment by Company, I will not (a) without Company’s express written consent,
engage in any employment or business activity that is competitive with, or would otherwise conflict with my employment by, Company; and
(b) for the period of my employment by Company and for one (1) year thereafter, I will not either directly or indirectly, solicit or attempt
to solicit any employee, independent contractor, or consultant of Company to terminate his, her or its relationship with Company in order
to become an employee, consultant, or independent contractor to or for any other person or entity.

 

5. RETURN
OF COMPANY PROPERTY. Upon termination of my employment or upon Company’s request at any other time, I will deliver to Company
all of Company’s property, equipment, and documents, together with all copies thereof, and any other material containing or disclosing
any Inventions, Third Party Information or Confidential Information and certify in writing that I have fully complied with the foregoing
obligation. I agree that I will not copy, delete, or alter any information contained upon my Company computer or Company equipment before
I return it to Company. In addition, if I have used any personal computer, server, or e-mail system to receive, store, review, prepare
or transmit any Company information, including but not limited to, Confidential Information, I agree to provide the Company with a computer-useable
copy of all such Confidential Information and then permanently delete and expunge such Confidential Information from those systems; and
I agree to provide the Company access to my system as reasonably requested to verify that the necessary copying and/or deletion is completed.
I further agree that any property situated on Company’s premises and owned by Company is subject to inspection by Company’s
personnel at any time with or without notice. Prior to the termination of my employment or promptly after termination of my employment,
I will cooperate with Company in attending an exit interview and certify in writing that I have complied with the requirements of this
section.

 

6. NOTIFICATION
OF NEW EMPLOYER. If I leave the employ of Company, I consent to the notification of my new employer of my rights and obligations under
this Agreement, by Company providing a copy of this Agreement or otherwise.

 

7. GENERAL
PROVISIONS.

 

7.1 Governing
Law and Venue. This Agreement and any action related thereto will be governed and interpreted by and under the laws of the State of
California, without giving effect to any conflicts of laws principles that require the application of the law of a different state. I
expressly consent to personal jurisdiction and venue in the state and federal courts for the county in which Company’s principal
place of business is located for any lawsuit filed there against me by Company arising from or related to this Agreement.

 

    Ex A-4

     

    

 

7.2 Severability.
If any provision of this Agreement is, for any reason, held to be invalid or unenforceable, the other provisions of this Agreement will
remain enforceable and the invalid or unenforceable provision will be deemed modified so that it is valid and enforceable to the maximum
extent permitted by law.

 

7.3 Survival.
This Agreement shall survive the termination of my employment and the assignment of this Agreement by Company to any successor or other
assignee and shall be binding upon my heirs and legal representatives.

 

7.4 Employment.
I agree and understand that nothing in this Agreement shall give me any right to continued employment by Company, and it will not interfere
in any way with my right or Company’s right to terminate my employment at any time, with or without cause and with or without advance
notice.

 

7.5 Notices.
Each party must deliver all notices or other communications required or permitted under this Agreement in writing to the other party at
the address listed on the signature page, by courier, by certified or registered mail (postage prepaid and return receipt requested),
or by a nationally-recognized express mail service. Notice will be effective upon receipt or refusal of delivery. If delivered by certified
or registered mail, notice will be considered to have been given five (5) business days after it was mailed, as evidenced by the postmark.
If delivered by courier or express mail service, notice will be considered to have been given on the delivery date reflected by the courier
or express mail service receipt. Each party may change its address for receipt of notice by giving notice of the change to the other party.

 

7.6 Injunctive
Relief. I acknowledge that, because my services are personal and unique and because I will have access to the Confidential Information
of Company, any breach of this Agreement by me would cause irreparable injury to Company for which monetary damages would not be an adequate
remedy and, therefore, will entitle Company to injunctive relief (including specific performance). The rights and remedies provided to
each party in this Agreement are cumulative and in addition to any other rights and remedies available to such party at law or in equity.

 

7.7 Waiver.
Any waiver or failure to enforce any provision of this Agreement on one occasion will not be deemed a waiver of that provision or any
other provision on any other occasion.

 

7.8 Export.
I agree not to export, reexport, or transfer, directly or indirectly, any U.S. technical data acquired from Company or any products utilizing
such data, in violation of the United States export laws or regulations.

 

7.9 Counterparts.
This Agreement may be executed in one or more counterparts, each of which shall be deemed an original and all of which shall be taken
together and deemed to be one instrument.

 

7.10 Entire
Agreement. If no other agreement governs nondisclosure and assignment of inventions during any period in which I was previously employed
or am in the future employed by Company as an independent contractor, the obligations pursuant to sections of this Agreement titled Confidential
Information Protections and Inventions shall apply. This Agreement is the final, complete and exclusive agreement of the parties with
respect to the subject matter hereof and supersedes and merges all prior communications between us with respect to such matters. No modification
of or amendment to this Agreement, or any waiver of any rights under this Agreement, will be effective unless in writing and signed by
me and the CEO of Company. Any subsequent change or changes in my duties, salary or compensation will not affect the validity or scope
of this Agreement.

 

    Ex A-5

     

    

This Agreement shall be effective as of the first day of my employment
with Company.

 

	EMPLOYEE:	 	COMPANY:
	 	 	 
	I HAVE READ, UNDERSTAND, AND ACCEPT THIS AGREEMENT AND HAVE BEEN GIVEN THE OPPORTUNITY TO REVIEW IT WITH INDEPENDENT LEGAL
    COUNSEL.	 	ACCEPTED AND AGREED:
	 	 	 
	/s/ Kenneth Siegel	 	/s/ Jamie Bechtel
	(Signature)	 	(Signature)
	 	 	 
	Kenneth Siegel	 	Jamie Bechtel
	By:	 	By:
	 	 	 
	Self	 	Chair Board of Directors
	Title:	 	Title:
	 	 	 
	January 3, 2023	 	December 30, 2022
	Date:	 	Date:
	 	 	 
	10169 Tavistock Road, Orlando, Florida 32827	 	4098 Mattson Pl., Bainbridge Is WA 98110
	Address:	 	Address:

 

    Ex A-6

     

    

 

EXHIBIT A

 

INVENTIONS

 

1. Prior
Inventions Disclosure. The following is a complete list of all Prior Inventions (as provided in Subsection 2.2 of the attached Confidential
Information and Inventions Assignment Agreement, defined herein as the “Agreement”):

 

		☒	None

 

		☐	See immediately below:
	 	 	 
	 	 	None.

 

 

 

Ex A-7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}]]